Speakers

Speakers

IMPORTANT DATES

Abstract Submission Deadline

24 June 2022

The selected abstracts will be announced at June 25, 2022

Mutlu Demiray, TÜRKİYE
Tümör Agnostik Çağda Kanser Tedavisi ve Klinik Kanser Biyologlarının Rolü

 

Abdullah Kahraman, TÜRKİYE – ONLINE
Comprehensive Genomic Profiling and Its Interpretation at Molecular Tumor Boards

 

Atıl Bişgin, TÜRKİYE
Kanser Tanı ve Tedavisinde Gelecek Vizyonu: Klinik Uygulamalarıyla Geniş Genomik Profilleme Gerçek Dünya Verileri

 

Aslı Kutlu, TÜRKİYE
Moleküler Biyoloji ve Genetik Bakış Açısı ile Kişiye Özel Kanser Tedavileri

 

Alexandre Tavartkiladze, GEORGIA – ONLINE
The new aspects in personalized cancer treatment

 

Engin Ulukaya, TÜRKİYE
Workshop: Correct Interpretation of Cell Death & Cytotoxicity Results

 

Nazlıhan Aztopal, TÜRKİYE
Workshop: Correct Interpretation of Cell Death & Cytotoxicity Results

 

Barış Korkmaz, FRANCE – ONLINE
Cathepsin C inhibition as a potential treatment strategy in cancer

 

Chiara Raggi, ITALY – ONLINE
Metabolic Aspects of Cholangiocarcinoma Stem-Compartment

 

Kıvanç Görgülü, GERMANY – ONLINE
Metabolic Dimensions of Metastatic Pancreatic Cancer

 

Ali Aktekin, TÜRKİYE
Cerrah Gözüyle Moleküler Onkolojiye Bakış

 

Ercan Öğreden, TÜRKİYE
Prostat Kanserinde Epidemiyoloji Etyoloji Tanı ve Evreleme

 

İbrahim Boga, TÜRKİYE
Kanserde Mutasyon İmzası Tespitine Yönelik Genom Analizleri ve Biyoinformatik Süreçler

 

İlker Şengül, TÜRKİYE
“Zooming” in thyroid nodules with indeterminate cytology in suspense; 10-15 mm with AUS/FLUS, TBSTRC

 

Konstantinos Dimas, GREECE – ONLINE
Development and characterization of a novel lipid-rich breast cancer patient-derived xenograft (PDX)
 
Didem Karakaş Zeybek, TÜRKİYE
Nerves in Pancreatic Cancer: The Unusual Suspects in Cancer Aggressiveness
 
Öykü Gönül Geyik, TÜRKİYE
Intratumor heterogeneity and Drug Resistance in Colorectal Cancer
 
Caner Geyik, TÜRKİYE
Multifaceted Roles of Nrf-2 in Cancer
 
Onur Emre Onat, TÜRKİYE
Gene discovery strategies in complex diseases: A novel rare variant association approach using next generation sequencing
 
Şehime Gülsün Temel, TÜRKİYE
Multidisiplinary Aporoach to the Personalized Cancer Diagnosis and
Treatmeant: Translation of Genomic Data in to the Clinic
 
Gamze Tanrıöver, TÜRKİYE
Rottlerin’in keskin kılıcı tümör mikroçevresindeki MDSC’leri harakiriye zorlar
 
Bülent Özpolat – USA
MicroRNA-Therapeutics in Cancer – The New Kid in the Block
 
Özlem Er – TÜRKİYE
Solid Tümörlerde Kapsamlı Genomik Profilleme Hangi Hastalara Yapılmalı?
Menu